European Companies Search Engine

EU funding (€6,846,157): SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients Hor1 Jul 2022 EU Research and Innovation programme "Horizon"

Text

The filing refers to a past date, and does not necessarily reflect the current state.

Creative Commons License The visualizations for "Associazione Frascati Scienza - EU funding (€6,846,157): SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.